[Asymptomatic bleeding into the posterior cranial fossa in the newborn].
E B
EB
Ol'khova
A S
AS
Kirsanov
N V
NV
Zlygareva
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000933:Antifibrinolytic Agents / Q000627:therapeutic use; D058070:Asymptomatic Diseases; D001688:Biological Products / Q000627:therapeutic use; D002439:Cefotaxime / Q000627:therapeutic use; D003388:Cranial Fossa, Posterior / Q000000981:diagnostic imaging*; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D020300:Intracranial Hemorrhages / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy; D008991:Monitoring, Physiologic / Q000379:methods; D009460:Neurologic Examination; D010949:Plasma; D012307:Risk Factors; D036542:Tomography, Spiral Computed / Q000379:methods*; D016896:Treatment Outcome; D024483:Vitamin K 3 / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D000933:Antifibrinolytic Agents; D001688:Biological Products; D024483:Vitamin K 3; C010546:bifidobacterin; D002439:Cefotaxime